LENZ · NASDAQ · Biotechnology

LENZ (LENZ)

Commercializes VIZZ, an FDA-approved aceclidine eye drop for adult presbyopia.

$4.18
After hours+0.05 (+1.26%)
At close$4.13(+1.10%)

Dividend yield
Next ex-date
Annual dividend
Schedule

Per share, Mar 2024DividendAnnual yield

Mar '24Mar '24
Dividend$7.21$7.21
Annual yield45.60%89.01%
Ex-dateMar 15Mar 22
Payment date

2 payments since Mar 2024

Ex-dateRecordPaidAmountNote
Mar 22, 2024Mar 18, 2024$1.03
Mar 15, 2024$1.03